Is There Sufficient Clinical Evidence To Reschedule Cannabis?


By Lydia Kariuki The US Drug Enforcement Administration (DEA) classifies all prescription drugs less than five distinctive groups (from agenda I, to V). The listing and scheduling of prescription drugs by the DEA is contained in the Managed substances act (CSA). At present, hashish is labeled less than plan 1 in the US, jointly with other […]